BOT 5.97% 35.5¢ botanix pharmaceuticals ltd

Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-178

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 493 Posts.
    lightbulb Created with Sketch. 126
    Yes, yes , I realise it’s all  a bit vulgar to attempt to preempt any future SP , not to mention it’s probably a little bit of bad juju , but bugger it , I’m hot and the surf is garbage ( again ) it’s too windy to fish and there’s been that many white pointers sighted around here that I feel if I jump in and spear the measliest of  fish or I’ll be set upon by dozens of them within milliseconds , so.....


    what is the realistic endpoint for BOT as far as you’re concerned ? At which SP would you imagine ( fantasise ) that we’d be bought out or what realistic price to you hope the SP could attain WITHIN 2 YERS.

    So by January 2020 , where do you hope we’d be ?


    Just a possible SP , you can justify it with industry parallels if you’d like to bolster your argument. Thanks for participating....if indeed you could be arsed.





 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
0.020(5.97%)
Mkt cap ! $707.4M
Open High Low Value Volume
33.5¢ 36.0¢ 33.3¢ $2.622M 7.530M

Buyers (Bids)

No. Vol. Price($)
5 106888 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 462320 5
View Market Depth
Last trade - 16.10pm 26/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.